FDA Adverse Event Malfunction Summary report: N

SENTINOL SELF-EXPANDING NITINOL BILIARY STENT SYSTEM

MDR report key: 925322 · Received March 30, 2007

Report

Report Number
6000093-2007-00682
Event Type
Malfunction
Date Received
March 30, 2007
Date of Event
March 1, 2007
Report Date
March 2, 2007
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
FGE
PMA / PMN Number
K032025
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE COMPLAINANT INDICATED THAT THE STENT REMAINS IMPLANTED AND THE DELIVERY DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS IS NOT AVAILABLE, AND WE ARE NOT ABLE TO DETERMINE THE ROOT CAUSE OF THIS EVENT. THE MFG RECORDS FOR BATCH 9111850 HAVE BEEN REVIEWED AND NO ISSUES OR DISCREPANCIES WERE FOUND. THIS RECORDS REVIEW CONFIRM THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY, AND PERFORMANCE SPECIFICATIONS.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING AN ANGIOPLASTY AND STENTING TREATMENT PROCEDURE IN THE SFA, CATHETER REMOVAL DIFFICULTIES OCCURRED. "AFTER THEY DEPLOYED THE STENT THEY TRIED TO REMOVE THE STENT CATHETER AND IT GOT STUCK ON THE WIRE, HAD TO REMOVE THE WHOLE CATHETER AND WIRE." THE STENT CATHETER WAS INSERTED AND ADVANCED OVER THE WIRE WITHOUT DIFFICULTY. THE STENT WAS FULLY DEPLOYED, WELL APPOSED AND REMAINS IMPLANTED IN THE PATIENT. WHEN THE PHYSICIAN ATTEMPTED TO REMOVE THE STENT CATHETER AFTER DEPLOYMENT, IT APPEARED THAT THE DISTAL PART OF THE DEVICE WAS CAUGHT ON THE GUIDEWIRE. THE STENT CATHETER AND GUIDEWIRE HAD TO BE REMOVED TOGETHER AS A UNIT. THE PHYSICIAN WAS REQUIRED TO REGAIN ACCESS. THE PROCEDURE WAS SUCCESSFULLY COMPLETED WITH ANOTHER OF THE SAME DEVICE. THERE WERE NO REPORTED PATIENT COMPLICATIONS AND THE CURRENT PATIENT STATUS IS REPORTED AS "FINE."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 SENTINOL SELF-EXPANDING NITINOL BILIARY STENT SYSTEM FGE CATHETER, BILIARY, DIAGNOSTIC FGE BOSTON SCIENTIFIC CORPORATION NA 9111850

Patients

Seq Age Sex Outcome Treatment
1 * ROSEN GUIDEWIRE